Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis

Infection and Immunity

Volumn 73, Issue 10, 2005, Pages 6601-6607

  Adlowitz, Diana G ^a,b   Sethi, Sanjay ^a,b   Cullen, Paul ^c   Adler, Ben ^c   Murphy, Timothy F ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EPITOPE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; PALMITIC ACID; PLASMID VECTOR; PROTEIN G1A; RECOMBINANT PROTEIN; TRITIUM; UNCLASSIFIED DRUG;

ADSORPTION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL COLONIZATION; CHEMICAL LABELING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COVALENT BOND; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MORAXELLA CATARRHALIS; MUCOSAL IMMUNITY; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RESPIRATORY TRACT INFECTION; SERUM; SPUTUM ANALYSIS; SUPERNATANT;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CLONING, MOLECULAR; GENES, BACTERIAL; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; LIPOPROTEINS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 25444451871     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.10.6601-6607.2005     Document Type: Article

References (50)

1. Adlowitz, D. G., T. Hiltke, A. J. Lesse, and T. F. Murphy. 2004. Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis. Vaccine 22:2533-2540.
2. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:877-8121.
3. Bartos, L. C., and T. F. Murphy. 1988. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J. Infect. Dis. 4:761-765.
4. Bessler, W. G., W. Baier, U. vd Esche, P. Hoffmann, L. Heinevetter, K. H. Wiesmuller, and G. Jung. 1997. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization. Behring Inst. Mitt. 1997:390-399.
5. Bessler, W. G., and G. Jung. 1992. Synthetic lipopeptides as novel adjuvants. Res. Immunol. 143:548-553.
6. Bhushan, R., C. Kirkham, S. Sethi, and T. F. Murphy. 1997. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Infect. Immun. 65:2668-2675.
7. Bogaerts, H., C. Capiau, P. Hauser, J. Mareschal, V. Melot, and D. Simons. 1996. Overview of the clinical development of a diptheria-tetanus- acellular pertussis vaccine. J. Infect. Dis. 174:8276-280.
8. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736.
9. Brunham, R. C., F. A. Plummer, and R. S. Stephens. 1993. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect. Immun. 61:2273-2276.
10. Christensen, J. J., N. Q. Hansen, and B. Bruun. 1996. Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection. Clin. Diagn. Lab. Immunol. 3:717-721.
11. Christensen, J. J., J. Renneberg, B. Bruun, and A. Forsgren. 1995. Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection. Clin. Diagn. Lab. Immunol. 2:14-17.
12. Cote-Sierra, J., A. Bredan, C. M. Toldos, B. Stijlemans, L. Brys, P. Cornelis, M. Segovia, P. de Baetselier, and H. Revets. 2002. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. Infect. Immun. 70:240-248.
13. Cullen, P. A., M. Lo, D. M. Bulach, S. J. Cordwell, and B. Adler. 2003. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 49:18-29.
14. Danese, P. N., W. B. Snyder, C. L. Cosma, L. J. Davis, and T. J. Silhavy. 1995. The Cpx two-component signal transduction pathway of Escherichia coli regulates transcription of the gene specifying the stress-inducible periplasmic protease, DegP. Genes Dev. 9:387-398.
15. DiGiuseppe, P. A., and T. J. Silhavy. 2003. Signal detection and target gene induction by the CpxRA two-component system. J. Bacteriol. 185:2432-2440.
16. Erdile, L. F., M. A. Brandt, D. J. Warakomski, G. J. Westrack, A. Sadziene, A. G. Barbour, and J. P. Mays. 1993. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61:81-90.
17. Fikrig, E., S. R. Telford III, S. W. Barthold, F. S. Kantor, A. Spielman, and R. A. Flavell. 1992. Elimination of Borrelia burgdorferi from vector ticks feeding on OSPA-immunized mice. Proc. Natl. Acad. Sci. USA 89:5418-5421.
18. Finlay, B. B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169.
19. Goldblatt, D., M. W. Turner, and R. J. Levinsky. 1990. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J. Infect. Dis. 162:1128-1135.
20. Gray, B. M., and H. C. Dillon, Jr. 1988. Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life. J. Infect. Dis. 158:948-955.
21. Gupta, S. D., B. T. O. Lee, J. Camakaris, and H. C. Wu. 1995. Identification of cutC and cutF (nlpE) genes involved in copper tolerance in Escherichia coli. J. Bacteriol. 177:4207-4215.
22. Hayashi, S., and H. C. Wu. 1990. Lipoproteins in bacteria. J. Bioenerg. Biomembr. 22:451-471.
23. Hewlett, E. L. 1997. Pertussis: current concepts of pathogenesis and prevention. Pediatr. Infect. Dis. J. 16:S78-S84.
24. Kane, J. F. 1995. Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. Curr. Opin. Biotechnol. 6:494-500.
25. Klein, J. O. 1994. Otitis media. Clin. Infect. Dis. 19:823-833.
26. Lopez, A. D., and C. C. Murray. 1998. The global burden of disease, 1990-2020. Nat. Med. 4:1241-1243.
27. Mannino, D. M. 2002. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121(Suppl. 5):121S-126S.
28. Mannino, D. M., D. M. Homa, L. J. Akinbami, E. S. Ford, and S. C. Redd. 2002. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Morb. Mortal. Wkly. Rep. Surveill. Summ. 51:1-16.
29. Mathers, K., M. Leinonen, and D. Goldblatt. 1999. Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media. Pediatr. Infect. Dis. J. 18:982-988.
30. McCool, T. L., T. R. Cate, G. Moy, and J. N. Weiser. 2002. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195:359-365.
31. McCool, T. L., T. R. Cate, E. I. Tuomanen, P. Adrian, T. J. Mitchell, and J. N. Weiser. 2003. Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect. Immun. 71:5724-5732.
32. Murphy, T. F. 1996. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:267-279.
33. Murphy, T. F. 1990. Studies of the outer membrane proteins of Branhamella catarrhalis. Am. J. Med. 88(Suppl. 5A):41S-45S.
34. Murphy, T. F., and L. A. Bartos. 1989. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect. Immun. 57:2938-2941.
35. Murphy, T. F., A. L. Brauer, C. Aebi, and S. Sethi. 2005. Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect. Immun. 73:3471-3478.
36. Murphy, T. F., A. L. Brauer, B. J. Grant, and S. Sethi. 2005. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am. J. Respir. Crit. Care Med. 172:195-199.
37. Murphy, T. F., C. Kirkham, D. F. Liu, and S. Sethi. 2003. Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect. Immun. 71:1288-1294.
38. Murphy, T. F., and S. Sethi, 1992. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Resp Dis. 146:1067-1083.
39. Murray, C. J., and A. D. Lopez. 1996. Evidence-based health policy - lessons from the Global Burden of Disease study. Science 274:740-743.
40. Musher, D. M., J. E. Groover, M. R. Reichler, F. X. Riedo, B. Schwartz, D. A. Watson, R. E. Baughn, and R. F. Breiman. 1997. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin. Infect. Dis. 24:441-446.
41. Otto, K., and T. J. Silhavy. 2002. Surface sensing and adhesion of Escherichia coli controlled by the Cpx-signaling pathway. Proc. Natl. Acad. Sci. USA 99:2287-2292.
42. Pelton, S. I., and J. O. Klein. 1999. The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr. Infect. Dis. J. 18:926-935.
43. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471.
44. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
45. Snyder, W. B., L. J. B. Davis, P. N. Danese, C. L. Cosma, and T. J. Silhavy. 1995. Overproduction of NIpE, a new outer membrane lipoprotein, suppresses the toxicity of periplasmic LacZ by activation of the Cpx signal transduction pathway. J. Bacteriol. 177:4216-4223.
46. Sorensen, M. A., C. G. Kurland, and S. Pedersen. 1989. Codon usage determines translation rate in Escherichia coli. J. Mol. Biol. 207:365-377.
47. Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, and D. S. Krause. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med. 339:209-215.
48. Stutzmann Meier, P., N. Heiniger, R. Troller, and C. Aebi. 2003. Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect. Immun. 71:6793-6798.
49. Thanassi, W. T., and R. T. Schoen. 2000. The Lyme disease vaccine: conception, development, and implementation. Ann. Intern. Med. 132:661-668.
50. Wu, H. C., and M. Tokunaga. 1986. Biogenesis of lipoproteins in bacteria. Curr. Top. Microbiol. Immunol. 125:127-157.